---
title: "YUYUE MEDICAL: Net profit in the first half of the year increased by 7.37% year-on-year, plans to distribute 2 yuan for every 10 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254134471.md"
description: "On the evening of August 22, YUYUE MEDICAL disclosed its semi-annual report for 2025. The company achieved operating revenue of 4.659 billion yuan in the first half of the year, a year-on-year increase of 8.16%; net profit attributable to the parent company was 1.203 billion yuan, a year-on-year increase of 7.37%; basic earnings per share were 1.2049 yuan. The company plans to distribute a cash dividend of 2 yuan for every 10 shares. During the reporting period, the company's blood glucose management and POCT solution business segments continued to maintain rapid growth, with revenue scale increasing by 20% year-on-year"
datetime: "2025-08-22T09:26:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254134471.md)
  - [en](https://longbridge.com/en/news/254134471.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254134471.md)
generator: "portal-rs"
---

# YUYUE MEDICAL: Net profit in the first half of the year increased by 7.37% year-on-year, plans to distribute 2 yuan for every 10 shares

On the evening of August 22, YUYUE MEDICAL disclosed its semi-annual report for 2025. The company achieved operating revenue of 4.659 billion yuan in the first half of the year, a year-on-year increase of 8.16%; net profit attributable to the parent company was 1.203 billion yuan, a year-on-year increase of 7.37%; basic earnings per share were 1.2049 yuan. The company plans to distribute a cash dividend of 2 yuan for every 10 shares. During the reporting period, the company's blood glucose management and POCT solution business segments continued to maintain rapid growth, with revenue scale increasing by 20% year-on-year

### Related Stocks

- [002223.CN](https://longbridge.com/en/quote/002223.CN.md)

## Related News & Research

- [Jiangsu Yuyue Medical Equipment & Supply: Net profit fell 29.92% year-over-year, but overseas and CGM sales grew sharply](https://longbridge.com/en/news/296602713.md)
- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [Scott Bessent Brings His Hedge Fund Playbook To Treasury. The Bond Market Is Fighting Back](https://longbridge.com/en/news/296520391.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**